Assessment of Knowledge and Performance Gaps in the Treatment of Patients with Multiple Myeloma

Noopur Raje, Rafat Abonour, Karen Overstreet, Karen Abbas, Jann Balmer, Betsy Dennison, Nelson G. N. Kalil, Patricia Mangan, Diane Moran, David H. Vesole


Background: The literature on the treatment of patients with multiple myeloma (MM) has grown enormously in the past decade, especially with the introduction of novel therapies. Appropriately designed continuing medical education (CME) activities could help extend improvements in treatment outcomes to more patients, including those outside of academic medical centers.

Methods: An expert panel of CME professionals and clinicians treating MM was convened. Panel members contributed evidence regarding educational needs in MM. This evidence was discussed iteratively, and a schema was devised for designing educational interventions to meet those needs.

Results: Five high-priority educational goals were matched with desired outcomes. These goals included appropriate use of advanced testing methods, management of drug toxicities, individualized selection of treatment intensity, patient selection for stem cell transplantation, and use of maintenance or consolidation therapy. Approaches for developing CME activities to meet these needs were briefly outlined.

Conclusions: Advances in MM therapy promise improved survival and quality of life for many patients. In view of the enormous amount and complexity of the data to be mastered, CME is of paramount importance in achieving these benefits. Approaches for designing effective CME were outlined as a result of these meetings of clinical and education experts.

Full Text:



  • There are currently no refbacks.